27-03-2020
In these challenging times, STERIS remains committed to supporting the ongoing needs of our Customers and their healthcare facilities. As a global leader in infection prevention technology we are working closely with our suppliers and end users to meet the demands for our products and services and contribute to supporting the delivery of patient care.
Our manufacturing facilities are fully operational, and we have increased production of Infection Prevention and Sterility Assurance Products at our Leicester facility to fulfil and support Customer requirements. Rest assured STERIS is doing everything possible to support our Customers during this exceptional global challenge.
At STERIS, we have received many questions relating to the effectiveness of our infection prevention solutions to inactivate COVID-19 and have produced a letter which can be downloaded via this link
In addition if you have any other specific enquiries about the application and use of STERIS reprocessing products, please contact us at ‘Device Testing'